Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids?

Affiliations

¹ Department of Dermatology, Allergy and Dermatosurgery, Helios Hospital Wuppertal, University Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Germany. silke.hofmann@helios-kliniken.de.

Comment

S C Hofmann. Br J Dermatol. 2015 Jul.

. 2015 Jul;173(1):17-8.

doi: 10.1111/bjd.13844.

¹ Department of Dermatology, Allergy and Dermatosurgery, Helios Hospital Wuppertal, University Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Germany. silke.hofmann@helios-kliniken.de.

No abstract available

Comment on

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.
Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group. Chalmers JR, et al. Br J Dermatol. 2015 Jul;173(1):227-34. doi: 10.1111/bjd.13729. Epub 2015 May 26. Br J Dermatol. 2015. PMID: 25683592 Clinical Trial.